# Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)

Study · id `cardio:ct-nct07441200` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07441200](<https://clinicaltrials.gov/study/NCT07441200>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07441200

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 135 participants.

## Technical summary

Registry record NCT07441200. Randomized; triple masking; primary purpose treatment. Start 2026-09-29 (actual); primary completion 2028-08-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 135 participants (planned count; ClinicalTrials.gov record NCT07441200, source copy `cardio:ctgov-nct07441200-2026-10-28`, retrieved 2026-10-31)
- Started: 2026-09-29 (actual) (ClinicalTrials.gov record NCT07441200, source copy `cardio:ctgov-nct07441200-2026-10-28`, retrieved 2026-10-31)
- Primary completion: 2028-08-01 (anticipated) (ClinicalTrials.gov record NCT07441200, source copy `cardio:ctgov-nct07441200-2026-10-28`, retrieved 2026-10-31)
- Completion: 2028-11-01 (anticipated) (ClinicalTrials.gov record NCT07441200, source copy `cardio:ctgov-nct07441200-2026-10-28`, retrieved 2026-10-31)
- Countries: Japan (ClinicalTrials.gov record NCT07441200, source copy `cardio:ctgov-nct07441200-2026-10-28`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07441200-2026-10-28`, retrieved 2026-10-31)

## The registry's words

- Brief title: Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
- Condition: Pulmonary Arterial Hypertension
- Intervention (Drug): NS-863 Low Dose
- Intervention (Drug): NS-863 High Dose
- Intervention (Drug): NS-863 Placebo
- Lead sponsor: NS Pharma, Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: Nippon Shinyaku Co., Ltd.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary arterial hypertension (`cardio:pulmonary-arterial-hypertension`)
- Registry condition terms include this condition: Pulmonary hypertension (`cardio:pulmonary-hypertension`)

## Provenance

Content hash: 9da380f83e0d9dc692c4d73af1b6dfbc40608a84103949acb19ba6658de893a9
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
